Target intelligence / Profile preview

Tripartite motif-containing protein 54 (TRIM54)

Target
TRIM54
Molecular classification
E3 ubiquitin-protein ligase, Tripartite motif-containing protein (TRIM family), RING finger protein, Cytoplasmic protein
01

Overview

Tripartite motif-containing protein 54 (TRIM54) is a cytoplasmic E3 ubiquitin ligase belonging to the TRIM family, characterized by a RING-type domain and responsible for regulating protein degradation via the ubiquitin-proteasome pathway. Highly expressed in striated muscle, heart, and testis, TRIM54 modulates skeletal muscle development, myotube formation, and microtubule stability. In cancer cells, TRIM54 acts as an oncogene: in hepatocellular carcinoma, it promotes proliferation and metastasis by degrading Axin1 and upregulating Wnt/β-catenin signaling; in gastric cancer, TRIM54 facilitates tumor progression via K63-linked ubiquitination and degradation of filamin C. TRIM54 expression serves as a prognostic biomarker for several cancers and acute myocardial infarction. While a promising therapeutic target due to its role in multiple pathological processes (muscular, cardiovascular, oncological diseases), direct inhibitors are not currently available and its inhibition may pose risks to muscle function

Other names
TRIM54MURF3RNF30MuRF-3Muscle-specific RING finger protein 3RING finger protein 30
02

Mechanism of action

E3 ubiquitin ligase activity: facilitates polyubiquitination and proteasomal degradation of negative regulators such as Axin1 (leading to Wnt/β-catenin signaling activation). K63-linked ubiquitination and degradation of filamin C (FLNC), affecting cell structure and migration.

03

Biological functions

Ubiquitination (protein degradation via the ubiquitin-proteasome pathway)Regulation of skeletal muscle development and adaptationStabilization of microtubules during myotube formationSignal transduction (Wnt/β-catenin pathway modulation)Regulation of cell proliferation and metastasis
04

Disease associations

Cancer (acting as an oncogene in hepatocellular carcinoma and gastric cancer)Cardiovascular disease (biomarker in acute myocardial infarction)Neuromuscular disease (associated with Charcot-Marie-Tooth disease, protein aggregate myopathies)Other (skeletal muscle adaptation and maintenance defects)
05

Safety considerations

Potential for increased tumorigenesis and metastasis if TRIM54 is overexpressedTargeting may disrupt muscle function or adaptation due to its role in muscle protein turnoverPotential for off-target effects in tissues with high TRIM54 expression, such as muscle and testis
06

Interacting drugs

Small molecule Wnt/β-catenin pathway inhibitors (shown to suppress TRIM54-induced proliferation in hepatocellular carcinoma models)

1 more in the full profile.

07

Biomarkers

TRIM54 protein and mRNA expression in tumor and muscle tissuesTRIM54 level as a prognostic biomarker for hepatocellular carcinoma and gastric cancerMutational status for diagnosis of acute myocardial infarction and muscle protein aggregate myopathies

Beyond the preview

Go deeper on Tripartite motif-containing protein 54 (TRIM54).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tripartite motif-containing protein 54 (TRIM54).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call